Market Cap 15.80B
Revenue (ttm) 14.81B
Net Income (ttm) 2.66B
EPS (ttm) N/A
PE Ratio 10.04
Forward PE 12.24
Profit Margin 17.93%
Debt to Equity Ratio 1.63
Volume 3,877,600
Avg Vol 4,800,816
Day's Range N/A - N/A
Shares Out 510.59M
Stochastic %K 90%
Beta 0.59
Analysts Sell
Price Target $37.12

Latest News on BAX

Baxter to Present at 7th Annual Evercore HealthCONx Conference

Nov 19, 2024, 4:15 PM EST - 2 months ago

Baxter to Present at 7th Annual Evercore HealthCONx Conference


Baxter to Present at Jefferies London Healthcare Conference

Nov 13, 2024, 4:15 PM EST - 2 months ago

Baxter to Present at Jefferies London Healthcare Conference


Baxter to Present at Stifel 2024 Healthcare Conference

Nov 12, 2024, 4:15 PM EST - 2 months ago

Baxter to Present at Stifel 2024 Healthcare Conference


Baxter Declares Quarterly Dividend

Nov 11, 2024, 6:45 PM EST - 2 months ago

Baxter Declares Quarterly Dividend


Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript

Nov 8, 2024, 12:16 PM EST - 2 months ago

Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript


Baxter cuts annual profit forecast on hurricane impact

Nov 8, 2024, 7:35 AM EST - 2 months ago

Baxter cuts annual profit forecast on hurricane impact


Baxter Reports Third-Quarter 2024 Results

Nov 8, 2024, 7:15 AM EST - 2 months ago

Baxter Reports Third-Quarter 2024 Results


Baxter restarts IV solutions manufacturing line

Oct 31, 2024, 11:43 AM EDT - 2 months ago

Baxter restarts IV solutions manufacturing line


Baxter to Present at UBS Global Healthcare Conference

Oct 23, 2024, 4:15 PM EDT - 3 months ago

Baxter to Present at UBS Global Healthcare Conference


Baxter to import 18,000 tons of IV products to US by year-end

Oct 17, 2024, 1:15 PM EDT - 3 months ago

Baxter to import 18,000 tons of IV products to US by year-end


Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore

Oct 14, 2024, 9:14 AM EDT - 3 months ago

Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore


Does Baxter Stock Offer Any Room For Growth?

Oct 1, 2024, 8:00 AM EDT - 3 months ago

Does Baxter Stock Offer Any Room For Growth?


Broyhill's Q2 2024 Top Five Investments

Sep 13, 2024, 4:00 AM EDT - 4 months ago

Broyhill's Q2 2024 Top Five Investments

AVTR FI PM


Baxter Appoints Jeffrey A. Craig to Its Board

Sep 9, 2024, 9:00 AM EDT - 4 months ago

Baxter Appoints Jeffrey A. Craig to Its Board


Spectral Medical Provides August Tigris Trial Update

Sep 3, 2024, 7:30 AM EDT - 4 months ago

Spectral Medical Provides August Tigris Trial Update

CG


Baxter to Present at 2024 Wells Fargo Healthcare Conference

Aug 28, 2024, 4:15 PM EDT - 5 months ago

Baxter to Present at 2024 Wells Fargo Healthcare Conference


Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion

Aug 19, 2024, 4:15 PM EDT - 5 months ago

Baxter To Sell Its Kidney Care Unit To Carlyle For $3.8 Billion


Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment

Aug 13, 2024, 11:07 AM EDT - 5 months ago

Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment

CG


Baxter- Reiterating Our Buy Rating After A Promising Q2

Aug 7, 2024, 12:12 PM EDT - 5 months ago

Baxter- Reiterating Our Buy Rating After A Promising Q2


Baxter International Inc. (BAX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 12:21 PM EDT - 5 months ago

Baxter International Inc. (BAX) Q2 2024 Earnings Call Transcript


Baxter Reports Second-Quarter 2024 Results

Aug 6, 2024, 7:15 AM EDT - 5 months ago

Baxter Reports Second-Quarter 2024 Results


Baxter: Why Investors Should Take Advantage Of The Low Valuation

Jul 16, 2024, 4:38 PM EDT - 6 months ago

Baxter: Why Investors Should Take Advantage Of The Low Valuation


Baxter to Present at Jefferies 2024 Global Healthcare Conference

May 23, 2024, 4:15 PM EDT - 8 months ago

Baxter to Present at Jefferies 2024 Global Healthcare Conference